Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Holly Elizabeth Rawizza, M.D.

Concepts (100)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Holly Rawizza's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Holly Rawizza has written about over time.
Peptide Hydrolases, 1 publications between 2013 and 2013, average publication date September 2013. Chemoprevention, 1 publications between 2015 and 2015, average publication date December 2014. Lost to Follow-Up, 2 publications between 2015 and 2015, average publication date December 2014. Anti-Retroviral Agents, 3 publications between 2015 and 2015, average publication date April 2015. Infectious Disease Transmission, Vertical, 2 publications between 2015 and 2017, average publication date January 2016. HIV Protease Inhibitors, 2 publications between 2008 and 2024, average publication date August 2016. Endocarditis, 1 publications between 2016 and 2016, average publication date September 2016. Endophthalmitis, 1 publications between 2016 and 2016, average publication date September 2016. Whipple Disease, 1 publications between 2016 and 2016, average publication date September 2016. Zidovudine, 3 publications between 2015 and 2017, average publication date December 2016. HIV Infections, 16 publications between 2008 and 2024, average publication date July 2017. Nigeria, 8 publications between 2011 and 2023, average publication date July 2017. Anti-HIV Agents, 7 publications between 2011 and 2024, average publication date August 2017. Ritonavir, 5 publications between 2008 and 2024, average publication date September 2018. HIV-1, 4 publications between 2013 and 2023, average publication date September 2018. Antibiotics, Antitubercular, 2 publications between 2019 and 2019, average publication date August 2019. Tuberculosis, 5 publications between 2013 and 2024, average publication date August 2019. Rifabutin, 3 publications between 2019 and 2024, average publication date October 2021.

To see the data from this visualization as text, click here.
Rawizza's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (100)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.